Life Science News

Cloud DX (TSXV:CDX) and Maxwell Telecare are announcing a new partnership to bring round-the-clock virtual care and real-time vital sign monitoring to residents living in long term care (LTC) facilities

The new solution, which combines Maxwell Telecare's on-demand telemedicine for post-acute care with Cloud DX's remote patient monitoring and diagnostic platform, is available now to healthcare partners in the US Midwest and Northwest. It will allow LTC and residential care providers to improve quality of care by reacting more swiftly to changing patient conditions, deliver care with greater efficiency, and ultimately reduce the need and costs of unnecessary hospitalizations. Under the initial 36-month agreement, Maxwell agrees to purchase Cloud DX products and services for deployment with all Maxwell customers in the United States. Maxwell will purchase Cloud DX on a per-patient-per-month basis for both Connected Health Kit and connectivity services deployed.

Maxwell Telecare prevents 75%-80% of rehospitalizations by having two doctors permanently assigned to a nursing facility, along with an onsite staffer. Now, with the addition of Cloud DX's Connected Health kit, staff can capture key patient vital signs (weight, blood pressure, pulse oxygen, glucose levels and temperature) at regular intervals during the day from the comfort of the patient's living quarters and flow that data in real time back to Maxwell's physicians, giving them an in-the-moment picture of an individual's health. This means doctors can intervene more quickly, adjust medications on the fly, or even dispatch a home-care nurse to the patient's room to make a house call. As a result, patients end up in the emergency room less, are admitted into hospital less, live at home longer and feel more in control of their health.

To date, Maxwell has deployed Cloud DX Connected Health kits to its clients Northwest Pulmonary, Meadowbrook Care Center, Homecare Associates (HCA), and The Landings of Minnetonka, IL. Together these clients care for more than 25,000 patients who qualify for remote physiological monitoring reimbursable by Medicare and/or private insurance. Several additional deployments including with Anew Home Health of Indiana are planned in 2021.

With the U.S. healthcare system overwhelmed by the surge of COVID-19 patients, telemedicine helped stem the tide by screening seniors in nursing homes and assisted living facilities to avoid unnecessary hospitalizations, an all-too-common result of lack of access to physicians during nights and weekends. Patients transferred to a nursing facility have a 25% likelihood of hospital readmission within 30 days and many bounce back more than once. When a physician cannot be located in a timely manner, nurses usually send patients to already overburdened hospitals.

"By adding Cloud DX's remote patient monitoring into our telecare model, we are now embedding a first line of intelligence right into each of our care facilities. Cloud DX will be the vital diagnostic eyes and ears for our physicians, providing them with the information they need make better care decisions quickly," says Maxwell founder and CEO Andrew Rosenson, MD. "By preventing patients from returning to hospital post-acute care facilities, providers can realize a 9.4X annual return on investment."

"We chose Cloud DX above all other vendors because of their incredible customer service and responsiveness, their Connected Health Kit's ease of use and adoption, their high patient satisfaction scores and the real-time care insights the platform provides back to our doctors," says John Hawkins, Advisory Board Member for Maxwell Telecare. "This partnership is creating a strong differentiator for our company and will deliver improved outcomes for our clients and for patients in their care."

"Remote patient monitoring is allowing us to monitor a patient's progress far more thoroughly than has been possible in the past and provides care teams with unprecedented, near real-time insight into a patient's condition so their decline or progress can be carefully tracked," says Robert Kaul, CEO of Cloud DX. "The model Maxwell Telecare and Cloud DX are building together is creating a new gold-standard for LTC and residential facilities. Patients and their families deserve this kind of advanced, technology-enabled care right now, not years in the future."

Residential and LTC providers interested in learning more about the Maxwell Telecare service, powered by Cloud DX, can visit:

About Cloud DX
Accelerating virtual healthcare's future, Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place and deliver hospital-quality post-surgical care. Providers partnering with CloudDX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. CloudDX is the co-winner of the Qualcomm Tricorder XPRIZE, a Fast Company "World Changing Idea" finalist, a 2021 Edison Award winner and one of Canada's Ten most prominent Telehealth providers. Visit us at

About Maxwell Telecare
Maxwell Telecare provides networks of dedicated physicians accessible via telehealth to long-term and post-acute care facilities. We reduce unnecessary hospitalizations, support chronic care management, and keep companies and facilities financially viable while improving quality of care, and satisfaction of both patients and families.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

For media inquiries please contact:
Heather Racicot
Ignition Communications

For investor inquiries please contact:
Jay Bedard
Cloud DX Investor Relations

SOURCE: Cloud DX Inc.

View source version on

News Provided by ACCESSWIRE via QuoteMedia

BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET

BioHarvest Sciences Inc. Announces Live Quarterly Shareholder Update Event July 7, 2022, at 2:00 PM ET

 BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 7, 2022, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time).

BioHarvest Sciences CEO Ilan Sobel will host the event, which will include coverage of Q2 sales results and a detailed progress update on the 2022 Growth Priorities, with specific focus on the VINIA scale-up progress in the USA and on the Company's Cannabis market entry strategy into North America.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Nanalysis Announces Results of AGM and Appointment of New Director

Nanalysis Scientific Corp. ("the Company", ("the Company", TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ) a leader in portable NMR machines and MRI technology for healthcare and industrial applications, is pleased to report that all proposed resolutions were approved at the Company's Annual General and Special Meeting of shareholders held on June 22, 2022 (the "Meeting"). The number of directors was set at 7 and all director nominees, as listed in the Management Information Circular dated May 20, 2022 (the "Information Circular"), were elected as directors of the Company at the Meeting to serve for a one-year term and hold office until the next annual meeting of shareholders. According to the proxy votes received from shareholders, the results were as follows:

Nanalysis Scientific Corp. (CNW Group/Nanalysis Scientific Corp.)


% For

% Withheld

Sean Krakiwsky

96.566 %

3.434 %

Martin Burian

95.592 %

4.408 %

Werner Gartner

99.852 %

0.148 %

Michal Okoniewski

99.852 %

0.148 %

Guido Cloetens

95.628 %

4.372 %

Rene Lenggenhager

99.852 %

0.148 %

Kham Lin

99.609 %

0.391 %

Shareholders voted 99.85% in favor of setting the number of directors at seven, 99.6% in favor of appointing Ernst & Young LLP, as auditor of the Company for the ensuing year and to authorize the Directors of the Company to fix the auditor's remuneration and 98.1% in favor for the approval of an amended stock option plan of the Company.

Corporate Update

The Company is pleased to welcome Kham Lin to Nanalysis's Board of Directors with immediate effect following shareholder approval at the Meeting.

Mr. Lin is currently a Managing Director at Nanalysis and was formerly the President and Chief Executive Officer of KPrime Technologies before the Company's acquisition by Nanalysis.  Over twenty plus years, Mr. Lin built KPrime, into a manufacturing representative business for global companies like Agilent Technologies, Metrohm USA , Sartorius LPS Division, and Leidos.  KPrime has a portfolio of sales and services in scientific detection and measuring equipment, financing, and asset management for chemical and security industries.  Mr. Lin resides and works in Calgary, Alberta, Canada but also splits time in Phoenix, Arizona at KPrime Headquarters.

About Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA:1N1)

Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'. The company's business is what we term "MRI and NMR for industry". The company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. Nanalysis recently announced that it has begun selling a 100MHz device in 2020. The Company's new device will be the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.

With the recent acquisition of K'Prime, the company maintains a North American sales and service company of over 40 individuals who cover scientific instrumentation for pharma, food, chemical and oil & gas customers, as well as imaging systems for security applications.

Additionally, the Company has a 43% ownership in Quad Systems AG ("Quad Systems"), with an option to purchase the remaining shares.  Quad Systems is a Zurich-based Nuclear Magnetic Resonance (NMR) company focused on high-field NMR for pharmaceutical and other vertical markets.

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:

SOURCE Nanalysis Scientific Corp.

Cision View original content to download multimedia:

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Applied UV Continues Cannabis Market Expansion

Applied UV Continues Cannabis Market Expansion

Tru Infusion Places Significant Order

Largest Indoor Cannabis Cultivator in Arizona

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Greenlane Renewables Announces Results From 2022 Annual General Meeting of Shareholders

Greenlane Renewables Announces Results From 2022 Annual General Meeting of Shareholders

~All nominated directors and proposed resolutions approved by shareholders~

 Greenlane Renewables Inc. ("Greenlane") (TSX: GRN) (FSE: 52G) is pleased to announce the results from its 2022 Annual General Meeting of Shareholders held on June 22, 2022 (the "Meeting"). Shareholders approved all matters submitted to them for approval at the annual general meeting. The results of the voting are set forth below:

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Applied UV Receives Substantial Order from European Distributor

Applied UV Receives Substantial Order from European Distributor

Cellarius is One of Europe's Fastest Growing Companies

Expanding Airocide's Global Winery Market share

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Playground Ventures Announces Appointment of CFO

Playground Ventures Announces Appointment of CFO

Playground Ventures Inc. (CSE: PLAY) (the "Company" or "Playground") announces that Nidhi Kumra has resigned as the Company's Chief Financial Officer, effectively May 31, 2022. The Board of Directors and management would like to thank Ms. Kumra for her contributions to the Company and wish her every success in her future endeavors.

The Company is also pleased to announce that Kaylee Whitcroft, the Company's Operations Accounting Manager, has been appointed the Chief Financial Officer of the Company.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News